- Home
- GNLN vs IBIO Comparison
GNLN vs IBIO Comparison
Compare GNLN & IBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GNLN
- IBIO
- Stock Information
- Founded
- GNLN 2005
- IBIO 2008
- Country
- GNLN United States
- IBIO United States
- Employees
- GNLN N/A
- IBIO N/A
- Industry
- GNLN Durable Goods
- IBIO Biotechnology: Pharmaceutical Preparations
- Sector
- GNLN Consumer Discretionary
- IBIO Health Care
- Exchange
- GNLN Nasdaq
- IBIO Nasdaq
- Market Cap
- GNLN 12.9M
- IBIO 11.9M
- IPO Year
- GNLN 2019
- IBIO N/A
- Fundamental
- Price
- GNLN $3.42
- IBIO $0.95
- Analyst Decision
- GNLN
- IBIO Strong Buy
- Analyst Count
- GNLN 0
- IBIO 2
- Target Price
- GNLN N/A
- IBIO $5.50
- AVG Volume (30 Days)
- GNLN 73.2K
- IBIO 2.1M
- Earning Date
- GNLN 08-14-2025
- IBIO 09-05-2025
- Dividend Yield
- GNLN N/A
- IBIO N/A
- EPS Growth
- GNLN N/A
- IBIO N/A
- EPS
- GNLN N/A
- IBIO N/A
- Revenue
- GNLN $7,954,000.00
- IBIO $400,000.00
- Revenue This Year
- GNLN $1,541.21
- IBIO N/A
- Revenue Next Year
- GNLN N/A
- IBIO N/A
- P/E Ratio
- GNLN N/A
- IBIO N/A
- Revenue Growth
- GNLN N/A
- IBIO 77.78
- 52 Week Low
- GNLN $2.84
- IBIO $0.56
- 52 Week High
- GNLN $5,944.50
- IBIO $6.89
- Technical
- Relative Strength Index (RSI)
- GNLN 45.40
- IBIO 66.60
- Support Level
- GNLN $3.15
- IBIO $0.77
- Resistance Level
- GNLN $3.55
- IBIO $0.97
- Average True Range (ATR)
- GNLN 0.23
- IBIO 0.07
- MACD
- GNLN 0.10
- IBIO 0.01
- Stochastic Oscillator
- GNLN 54.00
- IBIO 88.81
About GNLN Greenlane Holdings Inc.
Greenlane Holdings Inc is a platform for the development and distribution of premium cannabis accessories, vape devices, and lifestyle products. It provides a wide array of consumer ancillary products and industrial ancillary products to thousands of cannabis producers, processors, brands, and retailers (Cannabis Operators). In addition, it serves specialty retailers, smoke shops, head shops, convenience stores, and consumers directly through its proprietary web stores and large online marketplaces such as Amazon. Its geographical segment includes the United States, Canada, and Europe. It derives a majority of revenue from the United States.
About IBIO iBio Inc.
iBio Inc is a preclinical stage biotechnology company that leverages the power of Artificial Intelligence (AI) for the development of precision antibodies. CDMO. Its technology stack is designed to minimize downstream development risks by employing AI-guided epitope-steering and monoclonal antibody (mAb) optimization.